Issue 63, 2024

Synthesis and biological evaluation of vioprolide B and its dehydrobutyrine-glycine analogue

Abstract

Herein, we describe the total synthesis of the depsipeptide vioprolide B and of an analogue, in which the (E)-dehydrobutyrine amino acid was replaced by glycine. The compounds were studied in biological assays which revealed cytotoxicity solely for vioprolide B presumably by covalent binding to cysteine residues of elongation factor eEF1A1 and of chromatin assembly factor CHAF1A.

Graphical abstract: Synthesis and biological evaluation of vioprolide B and its dehydrobutyrine-glycine analogue

Supplementary files

Article information

Article type
Communication
Submitted
18 Jun 2024
Accepted
05 Jul 2024
First published
15 Jul 2024
This article is Open Access
Creative Commons BY license

Chem. Commun., 2024,60, 8272-8275

Synthesis and biological evaluation of vioprolide B and its dehydrobutyrine-glycine analogue

N. Osorio Reineke, F. A. V. Elsen, H. A. Grab, D. Mostert, S. A. Sieber and T. Bach, Chem. Commun., 2024, 60, 8272 DOI: 10.1039/D4CC02946A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements